Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Insulin use and weight maintenance in well-controlled type 2 diabetes: a prospective cohort study.

Huizinga MM, Niswender KD, Gebretsadik T, Rothman RL, Shintani AK, Elasy TA.

Obesity (Silver Spring). 2008 Aug;16(8):1933-7. doi: 10.1038/oby.2008.301. Epub 2008 Jun 12.

2.

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.

PMID:
9398709
5.

Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes.

Heintjes EM, Thomsen TL, Penning-van Beest FJ, Christensen TE, Herings RM.

Adv Ther. 2010 Apr;27(4):211-22. doi: 10.1007/s12325-010-0020-y. Epub 2010 May 4.

PMID:
20449697
6.

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.

Phung OJ, Scholle JM, Talwar M, Coleman CI.

JAMA. 2010 Apr 14;303(14):1410-8. doi: 10.1001/jama.2010.405.

PMID:
20388897
7.
8.

Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting.

McAdam-Marx C, Bouchard J, Aagren M, Nelson R, Brixner D.

Diabetes Obes Metab. 2010 Jan;12(1):54-64. doi: 10.1111/j.1463-1326.2009.01128.x. Epub 2009 Sep 16.

PMID:
19758356
9.

Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

Yoon NM, Cavaghan MK, Brunelle RL, Roach P.

Clin Ther. 2009 Jul;31(7):1511-23. doi: 10.1016/j.clinthera.2009.07.021.

PMID:
19695400
10.

Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis.

Maggs D, Shen L, Strobel S, Brown D, Kolterman O, Weyer C.

Metabolism. 2003 Dec;52(12):1638-42.

PMID:
14669170
11.

Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.

Nansel TR, Lipsky LM, Iannotti RJ.

Diabetes Res Clin Pract. 2013 Apr;100(1):126-32. doi: 10.1016/j.diabres.2012.12.025. Epub 2013 Jan 20.

12.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
13.

[Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin].

Wilding JP, Woo V, Soler NG, Pahor A, Sugg J, Rohwedder K, Parikh S; Studiengruppe Dapagliflozin 006.

Dtsch Med Wochenschr. 2013 Apr;138 Suppl 1:S27-38. doi: 10.1055/s-0032-1305284. Epub 2013 Mar 25. German.

PMID:
23529568
14.
15.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
17.

Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S.

JAMA. 1997 Nov 26;278(20):1663-9. Erratum in: JAMA 1999 Jun 2;281(21):1989.

PMID:
9388085
18.

Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients.

Schütt M, Kern W, Zimmermann A, Busch P, Kerner W, Voll A, Wagner C, Kann PH, Dapp A, Holl RW; DPV initiative; German BMBF Competence Network Diabetes mellitus.

Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):490-5. doi: 10.1055/s-0030-1249024. Epub 2010 Mar 3.

PMID:
20200811
19.

Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.

Gross JL, Nakano M, Colon-Vega G, Ortiz-Carasquillo R, Ferguson JA, Althouse S, Tobian JA, Berclaz PY, Milicevic Z.

Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S27-34. doi: 10.1089/dia.2009.0037.

PMID:
19772446
20.

Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort.

Best JD, Drury PL, Davis TM, Taskinen MR, Kesäniemi YA, Scott R, Pardy C, Voysey M, Keech AC; Fenofibrate Intervention and Event Lowering in Diabetes Study Investigators.

Diabetes Care. 2012 May;35(5):1165-70. doi: 10.2337/dc11-1307. Epub 2012 Mar 19.

Items per page

Supplemental Content

Write to the Help Desk